GW786034
| GW786034 | |
|---|---|
| Term | GW786034 |
| Short definition | GW572016 - A drug used with capecitabine or letrozole to treat certain types of HER2-positive breast cancer that have progressed or spread. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
GW786034 - A medicine used to treat adults with advanced renal cell carcinoma (a type of kidney cancer) or advanced soft tissue sarcoma who have already been treated with other cancer medicines. It is also being studied in the treatment of other types of cancer. GW786034 blocks certain proteins that can prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis agent. Also called pazopanib hydrochloride and votrient
External links
- Medical encyclopedia article on GW786034
- Wikipedia's article - GW786034
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski